Literature DB >> 12880591

Expression of cysteine proteinase type I and II of Leishmania infantum and their recognition by sera during canine and human visceral leishmaniasis.

Sima Rafati1, Alireza Nakhaee, Tahere Taheri, Andishe Ghashghaii, Ali Hatef Salmanian, Maribel Jimenez, Mehdi Mohebali, Slavica Masina, Nicolas Fasel.   

Abstract

In this study, the mature domains of type I (CPB) and type II (CPA) cysteine proteinases (CPs) of Leishmania infantum were expressed and their immunogenic properties defined using sera from active and recovered cases of human visceral leishmaniasis and sera from infected dogs. Immunoblotting and ELISA analysis indicated that a freeze/thaw extract of parasite antigens showed similar and intensive recognition in both active cases of human and dog sera but lower recognition in recovered human individuals. The total IgG of actively infected human sera was higher than in recovered cases when rCPs were used as antigen. In contrast to dog sera, both active and recovered human cases have higher recognition toward rCPB than rCPA. Furthermore, the asymptomatic dogs in contrast to the symptomatic cases exhibited specific lymphocyte proliferation to both crude antigens and rCPs.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12880591     DOI: 10.1016/s0014-4894(03)00097-3

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  14 in total

1.  Recombinant cysteine proteinase from Leishmania (Leishmania) chagasi implicated in human and dog T-cell responses.

Authors:  Paulo Henrique da Costa Pinheiro; Suzana de Souza Dias; Kelsen Dantas Eulálio; Ivete L Mendonça; Simone Katz; Clara Lúcia Barbiéri
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

2.  Amastin peptide-binding antibodies as biomarkers of active human visceral leishmaniasis.

Authors:  Sima Rafati; Nafiseh Hassani; Yasaman Taslimi; Hesam Movassagh; Annie Rochette; Barbara Papadopoulou
Journal:  Clin Vaccine Immunol       Date:  2006-10

3.  Recombinant Cysteine Proteinase B from Leishmania braziliensis and Its Domains: Promising Antigens for Serodiagnosis of Cutaneous and Visceral Leishmaniasis in Dogs.

Authors:  A E Bivona; L Czentner; A Sanchez Alberti; N Cerny; A C Cardoso Landaburu; C Nevot; O Estévez; J D Marco; M A Basombrio; E L Malchiodi; S I Cazorla
Journal:  J Clin Microbiol       Date:  2019-10-23       Impact factor: 5.948

4.  Distinct antigen recognition pattern during zoonotic visceral leishmaniasis in humans and dogs.

Authors:  Yasuyuki Goto; Randall F Howard; Ajay Bhatia; Joelma Trigo; Maria Nakatani; Eduardo M Netto; Steven G Reed
Journal:  Vet Parasitol       Date:  2008-11-05       Impact factor: 2.738

5.  Specific serodiagnosis of canine visceral leishmaniasis using Leishmania species ribosomal protein extracts.

Authors:  Eduardo A F Coelho; Laura Ramírez; Mariana A F Costa; Vinicio T S Coelho; Vivian T Martins; Miguel A Chávez-Fumagalli; Dulcilene M Oliveira; Carlos A P Tavares; Pedro Bonay; Carlos Gómez Nieto; Daniel R Abánades; Carlos Alonso; Manuel Soto
Journal:  Clin Vaccine Immunol       Date:  2009-10-07

6.  Protective immunity and vaccination against cutaneous leishmaniasis.

Authors:  Ifeoma Okwor; Zhirong Mou; Dong Liu; Jude Uzonna
Journal:  Front Immunol       Date:  2012-05-29       Impact factor: 7.561

7.  Experimental Validation of Multi-Epitope Peptides Including Promising MHC Class I- and II-Restricted Epitopes of Four Known Leishmania infantum Proteins.

Authors:  Maria Agallou; Evita Athanasiou; Olga Koutsoni; Eleni Dotsika; Evdokia Karagouni
Journal:  Front Immunol       Date:  2014-06-10       Impact factor: 7.561

8.  Development of novel prime-boost strategies based on a tri-gene fusion recombinant L. tarentolae vaccine against experimental murine visceral leishmaniasis.

Authors:  Noushin Saljoughian; Tahereh Taheri; Farnaz Zahedifard; Yasaman Taslimi; Fatemeh Doustdari; Azam Bolhassani; Delaram Doroud; Hiva Azizi; Kazem Heidari; Mohammad Vasei; Nabiollah Namvar Asl; Barbara Papadopoulou; Sima Rafati
Journal:  PLoS Negl Trop Dis       Date:  2013-04-18

9.  Immunogenicity of HLA-DR1 Restricted Peptides Derived from Leishmania major gp63 Using FVB/N-DR1 Transgenic Mouse Model.

Authors:  H Rezvan
Journal:  Iran J Parasitol       Date:  2013-04       Impact factor: 1.012

10.  Diagnostic efficacy of a recombinant cysteine protease of Spirometra erinacei larvae for serodiagnosis of sparganosis.

Authors:  S M Mazidur Rahman; Jae-Hwan Kim; Sung-Tae Hong; Min-Ho Choi
Journal:  Korean J Parasitol       Date:  2014-02-19       Impact factor: 1.341

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.